These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32075969)

  • 1. A molecular switch regulating transcriptional repression and activation of PPARγ.
    Shang J; Mosure SA; Zheng J; Brust R; Bass J; Nichols A; Solt LA; Griffin PR; Kojetin DJ
    Nat Commun; 2020 Feb; 11(1):956. PubMed ID: 32075969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A structural mechanism for directing corepressor-selective inverse agonism of PPARγ.
    Brust R; Shang J; Fuhrmann J; Mosure SA; Bass J; Cano A; Heidari Z; Chrisman IM; Nemetchek MD; Blayo AL; Griffin PR; Kamenecka TM; Hughes TS; Kojetin DJ
    Nat Commun; 2018 Nov; 9(1):4687. PubMed ID: 30409975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ.
    Heidari Z; Chrisman IM; Nemetchek MD; Novick SJ; Blayo AL; Patton T; Mendes DE; Diaz P; Kamenecka TM; Griffin PR; Hughes TS
    Nat Commun; 2019 Dec; 10(1):5825. PubMed ID: 31862968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
    Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
    J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a conformational ensemble that directs activation of PPARγ.
    Chrisman IM; Nemetchek MD; de Vera IMS; Shang J; Heidari Z; Long Y; Reyes-Caballero H; Galindo-Murillo R; Cheatham TE; Blayo AL; Shin Y; Fuhrmann J; Griffin PR; Kamenecka TM; Kojetin DJ; Hughes TS
    Nat Commun; 2018 May; 9(1):1794. PubMed ID: 29728618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical Crosslinking Mass Spectrometry Reveals the Conformational Landscape of the Activation Helix of PPARγ; a Model for Ligand-Dependent Antagonism.
    Zheng J; Corzo C; Chang MR; Shang J; Lam VQ; Brust R; Blayo AL; Bruning JB; Kamenecka TM; Kojetin DJ; Griffin PR
    Structure; 2018 Nov; 26(11):1431-1439.e6. PubMed ID: 30146169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural mechanism underlying ligand binding and activation of PPARγ.
    Shang J; Kojetin DJ
    Structure; 2021 Sep; 29(9):940-950.e4. PubMed ID: 33713599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARγ Corepression Involves Alternate Ligand Conformation and Inflation of H12 Ensembles.
    Frkic RL; Pederick JL; Horsfall AJ; Jovcevski B; Crame EE; Kowalczyk W; Pukala TL; Chang MR; Zheng J; Blayo AL; Abell AD; Kamenecka TM; Harbort JS; Harmer JR; Griffin PR; Bruning JB
    ACS Chem Biol; 2023 May; 18(5):1115-1123. PubMed ID: 37146157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
    Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
    J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational Diversity of the Helix 12 of the Ligand Binding Domain of PPARγ and Functional Implications.
    Batista MR; Martínez L
    J Phys Chem B; 2015 Dec; 119(50):15418-29. PubMed ID: 26598113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis.
    Pochetti G; Mitro N; Lavecchia A; Gilardi F; Besker N; Scotti E; Aschi M; Re N; Fracchiolla G; Laghezza A; Tortorella P; Montanari R; Novellino E; Mazza F; Crestani M; Loiodice F
    J Med Chem; 2010 Jun; 53(11):4354-66. PubMed ID: 20462215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for PPARγ transactivation by endocrine-disrupting organotin compounds.
    Harada S; Hiromori Y; Nakamura S; Kawahara K; Fukakusa S; Maruno T; Noda M; Uchiyama S; Fukui K; Nishikawa J; Nagase H; Kobayashi Y; Yoshida T; Ohkubo T; Nakanishi T
    Sci Rep; 2015 Feb; 5():8520. PubMed ID: 25687586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.
    Shang J; Brust R; Mosure SA; Bass J; Munoz-Tello P; Lin H; Hughes TS; Tang M; Ge Q; Kamenekca TM; Kojetin DJ
    Elife; 2018 Dec; 7():. PubMed ID: 30575522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.
    Waku T; Shiraki T; Oyama T; Maebara K; Nakamori R; Morikawa K
    EMBO J; 2010 Oct; 29(19):3395-407. PubMed ID: 20717101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states.
    MacTavish B; Zhu D; Shang J; Shao Q; Yang ZJ; Kamenecka TM; Kojetin DJ
    bioRxiv; 2024 Apr; ():. PubMed ID: 38712087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
    Molnár F; Matilainen M; Carlberg C
    J Biol Chem; 2005 Jul; 280(28):26543-56. PubMed ID: 15888456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structural assessment of graded receptor agonism.
    Shang J; Brust R; Griffin PR; Kamenecka TM; Kojetin DJ
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22179-22188. PubMed ID: 31611383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
    Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
    J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands.
    Pochetti G; Godio C; Mitro N; Caruso D; Galmozzi A; Scurati S; Loiodice F; Fracchiolla G; Tortorella P; Laghezza A; Lavecchia A; Novellino E; Mazza F; Crestani M
    J Biol Chem; 2007 Jun; 282(23):17314-24. PubMed ID: 17403688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.